SUPPLY AGREEMENTSupply Agreement • November 10th, 2014 • Mannkind Corp • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 10th, 2014 Company Industry JurisdictionTHIS SUPPLY AGREEMENT (the “Agreement”) is made as of the 31st day of July, 2014 (the “Effective Date”) by and between MannKind Corporation, a Delaware corporation (“MannKind”), with its principal office and place of business at 28903 North Avenue Paine, Valencia, CA 91355, U.S.A., and Amphastar France Pharmaceuticals S.A.S., a French corporation (“AFP”), with its principal office and place of business at Usine Saint-Charles, 60590 Eragny-Sur-Epte, France (each of MannKind and AFP, a “Party” and together, the “Parties”).
SECOND AMENDMENT TO FACILITY AGREEMENTFacility Agreement • November 10th, 2014 • Mannkind Corp • Pharmaceutical preparations • New York
Contract Type FiledNovember 10th, 2014 Company Industry JurisdictionSECOND AMENDMENT TO FACILITY AGREEMENT (this “Amendment”), dated as of August 11, 2014, by and among MANNKIND CORPORATION, a Delaware corporation (the “Borrower”), DEERFIELD PRIVATE DESIGN FUND II, L.P. (“DPDF”) and DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P. (together with DPDF collectively referred to as the “Purchasers” and together with the Borrower, the “Parties”).
LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • November 10th, 2014 • Mannkind Corp • Pharmaceutical preparations • New York
Contract Type FiledNovember 10th, 2014 Company Industry Jurisdiction* Expiration dates are computer generated and may not take into account patent term adjustments, patent term extensions, terminal disclaimers or the like. These dates should be used as general guides only.
SUPPLY AGREEMENTSupply Agreement • November 10th, 2014 • Mannkind Corp • Pharmaceutical preparations • New York
Contract Type FiledNovember 10th, 2014 Company Industry JurisdictionThis SUPPLY AGREEMENT (together with all schedules attached hereto, the “Agreement”) is entered into as of August 11, 2014 (the “Execution Date”) and is effective as of the Effective Date (as defined in the License Agreement (as defined below)) between MANNKIND CORPORATION, a Delaware corporation (“MannKind”), having a principal place of business at 28903 North Avenue Paine, Valencia, California 91355, USA, and SANOFI-AVENTIS DEUTSCHLAND GMBH, a company organized and existing under the laws of Germany (“Sanofi”), with a place of business at 65926 Frankfurt am Main, Germany.